Case Reports

Palliative concurrent chemoradiation for gastrostomy site metastasis


 

Patients with head and neck squamous cell carcinoma typically present with dysphagia, odynophagia, and weight loss. Treatment of the disease with surgery or concurrent chemoradiation often results in local inflammation and limits further oral intake. Percutaneous endoscopic gastrostomy has been a common and effective means of nutritional support in these patients.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Intraoperative nerve stimulation reduces risk of shoulder pain from neck dissection
MDedge Hematology and Oncology
Preop G-tubes save money in head and neck cancer resections
MDedge Hematology and Oncology
Post-TORS neck dissections extend hospital stay
MDedge Hematology and Oncology
Clearing tumor bed margins may not improve oral cancer outcomes
MDedge Hematology and Oncology
Less pain, quicker discharge with post-TORS dexamethasone
MDedge Hematology and Oncology
Dental oncology in patients treated with radiation for head and neck cancer
MDedge Hematology and Oncology
ATA’s risk assessment guidelines for thyroid nodules using sonography patterns validated
MDedge Hematology and Oncology
Survival, QoL better with nivolumab for recurrent head and neck cancer
MDedge Hematology and Oncology
FDA approves nivolumab for advanced squamous cell carcinoma of the head and neck
MDedge Hematology and Oncology
Toxicity analysis of docetaxel, cisplatin, and 5- fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers
MDedge Hematology and Oncology